We next over-expressed the miR-17∼92 derivative miR-17∼19b in an inducible model of BCR-ABL-positive ALL, thereby identifying impaired apoptosis as a key determinant of reduced miR-17∼92 function in this disease setting. Here, ABL1 is linked to acute lymphoblastic leukemia.